A major pharmaceutical retailer has agreed to a $315 million settlement to resolve allegations that it improperly filled prescriptions for opioids and other controlled substances. The case stems from a whistleblower lawsuit filed in 2019, accusing the company of violating federal fraud laws by allegedly filling prescriptions without proper verification. The Justice Department announced the resolution as part of ongoing efforts to hold corporations accountable for potential misconduct in prescription drug distribution. The settlement marks one of the largest penalties of its kind in recent years, reflecting growing scrutiny over opioid-related practices in the healthcare industry.
The Justice Department (DOJ) announced Tuesday that CVS Health has agreed to pay $315 million to settle lawsuits alleging the company illegally filled prescriptions for opioids and other controlled substances. The settlement resolves a lawsuit first filed in 2019 by former CVS employee Hillary Estright in 2019 under the whistleblower provision of the False Claims...
